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 US MLE TEST 
A 58-year-old man with history of coronary artery disease, 
hypertension, and hyperlipidemia presents to an emergency 
department for evaluation of chest pain. He reports somewhat 
suddenly experiencing dull left-sided chest discomfort while at rest at 
home that was not relieved with taking nitroglycerin. His vital signs 
are: T 37.1, HR 94 beats per minute, BP 133/87, and O2 saturation 
97% on ambient air. His ECG (shown, figure A) shows no ST-segment 
changes; serum troponin is not elevated. His chest pain subsequently 
resolves and he is admitted to the cardiac service for further 
management. Which of the following is by itself not an indication for 
early percutaneous coronary intervention? 
1.  Hemodynamic instability, 2.  Positive cardiac biomarker, 3.  ST-
segment elevation on ECG, 4.  Recurrent or refractory chest pain,   
5.  Heart failure  
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 2:  This patient with known coronary 
artery disease (CAD) presents with angina at rest, thus 
the diagnosis is unstable angina, a variant of acute 
coronary syndrome (ACS). All of the above are strong 
indications for intervention except answer 2, positive 
cardiac biomarker, which alone is not enough to warrant 
this management. 
Incorrect Answers: 
Answers 1, 3-5: These are all strong indications for early 
PCI in patients with UA/NSTEMI.  
 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
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Definition 1 
Acute coronary syndrome (ACS)  has evolved as a 
useful operational term that refers to a spectrum 
of conditions compatible with acute myocardial 
ischemia and/or infarction (MI) that are usually 
due to an abrupt reduction in coronary blood 
flow ranging clinically from those for ST-segment 
elevation myocardial infarction (STEMI) to 
presentations found in non–ST-segment 
elevation myocardial infarction (NSTEMI) or in 
unstable angina (UA).  
 emedicine.medscape.com/article/1910735-overview content.onlinejacc.org/article.aspx?articleid=1910086 
Definition 2 
Most patients with STEMI develop QMI, and a 
few  develop NQMI. Most  of those without ST-
elevation develop NQMI and only a few may 
develop QMI 
The ACS associated with high healthcare costs, 
frequent recurrences and hospitalizations, and 
high risks of sudden death and short-term 
mortality. 
 emedicine.medscape.com/article/1910735-overview content.onlinejacc.org/article.aspx?articleid=1910086 
Definition 
 Unstable Angina 1  
• UA is defined as myocardial ischemia at rest or 
minimal exertion in the absence of 
cardiomyocyte necrosis  
• Among patients presenting with suspected 
NSTE-ACS, the introduction of high-sensitivity 
cardiac troponin measurements in place of 
standard troponin assays resulted in an 
increase in the detection of MI  and a 
reciprocal decrease in the diagnosis of UA.  
eurheartj.oxfordjournals.org/content/37/3/267   
Definition 
 Unstable Angina 2 
• Compared with NSTEMI patients, individuals 
with UA do not experience myocardial 
necrosis, have a substantially lower risk of 
death and appear to derive less benefit from 
intensified antiplatelet therapy as well as early 
invasive strategy. 
eurheartj.oxfordjournals.org/content/37/3/267   
Definition 
 Definitions of Myocardial Infarction 1 
• Universal: MI defines cardiomyocyte necrosis 
in a clinical setting consistent with acute 
myocardial ischemia.  
eurheartj.oxfordjournals.org/content/37/3/267 im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf  
Definition 
 Definitions of Myocardial Infarction 2 
• My: Acute myocardial infarction is a disease or 
a clinical syndrome accompanying other 
diseases, which is represented by acute 
coronarogenous aseptic inflammation of the 
part of a heart wall, and clinically correlates 
with stress reactions of body control systems 
and is determined by the extent, localization, 
nature, and stage of structural transformations 
in the infarction zone, as well as circulation 
changes, and their consequences. 
eurheartj.oxfordjournals.org/content/37/3/267 im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf  
 US MLE TEST 
A 63-year-old diabetic woman with a history of GERD is presenting to 
the ER in the afternoon with new onset abdominal pain. Her 
symptoms began while she was walking her dog this morning when 
she began to feel a dull, 3/10 pain in her mid-upper abdomen. She 
attributed this to her meal which contained bacon and eggs that 
morning and said that it felt similar to her usual GERD symptoms but 
was also accompanied by fatigue and nausea which made her 
anxious. Her last bowel movement was yesterday morning and was 
"normal." Physical exam was remarkable for a nervous elderly 
woman appearing her stated age. Vitals were within normal limits. 
No abnormalities were noted on HEENT, heart or lung exam. 
Abdominal exam showed a soft, nontender, nondistended abdomen 
with no guarding or rebound. Which of the following studies should 
be ordered first?  
1.  Abdominal X-ray , 2.  Electrocardiogram, 3.  Abdominal CT with 
contrast, 4.  Adbominal CT without contrast, 5.  Chest X-ray.   
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 2:  This patient is at a high risk for having a 
myocardial infarction with an atypcial presentation. Although 
abdominal pathology should be considered, it is absolutely vital that 
an electrocardiogram be performed to rule out myocardial ischemia 
as a cause of her symptoms.  
Incorrect Answers: 
1, 3, 4: These imaging studies are useful for investigating abdominal 
pathology which this patient may be presenting with. However, an 
ECG must be used to rule out a cardiac emergency first. Although an 
abdominal emergency is possible (e.g. small bowel obstruction, 
mesenteric ischemia, and perforated diverticulitis), her somewhat 
mild symptoms make these less likely., 5: A chest X-ray is not 
especially useful for investigating her acute cardiac or abdominal 
events unless a perforated bowel is suspected which is unlikely given 
the lack of severe symptoms. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Epidemiology   
 Acute Coronary Syndrome around the World 1 
eurheartj.oxfordjournals.org/content/33/20/2569 
• Worldwide, coronary artery disease (CAD) is 
the single most frequent cause of death   
• Over seven million people every year die from 
CAD, accounting for 12.8% of all deaths  
• Every sixth man and every seventh woman in 
Europe will die from myocardial infarction.  
Epidemiology   
 Acute Coronary Syndrome around the World 2 
eurheartj.oxfordjournals.org/content/33/20/2569 
• The incidence of hospital admissions for 
myocardial infarction varies among countries  
• The most comprehensive STEMI registry is 
probably in Sweden, where the incidence is 66 
STEMI/100 000/year.   
Epidemiology   
(Acute Coronary Syndrome in the Spanish Population) 
revespcardiol.org/en/epidemiology-of-acute-coronary-syndromes/articulo/90202863/ 
Number of acute coronary syndrome cases, trend 
from 2005 to 2049 by sex and age group in the 
Spanish population. ACS, acute coronary syndromes. 
Epidemiology   
(Troponin and Diagnosis of ST-elevated and non-ST-
elevated Acute Myocardial Infarction) 
nature.com/nrcardio/journal/v8/n3/images/nrcardio.2010.199-f2.jpg 
Quality of a diagnosis depends strictly from 
diagnostic procedures. 
Risk Factors 
mayoclinic.org/ image.slidesharecdn.com/asimnstemi-final-140204114442-phpapp01/95/acute-coronary-syndrome-nstemi-7-638.jpg?cb=1400815933 
The risk factors 
for an ACS are 
the same as 
those for other 
types of clinical 
atherosclerosis 
including heart 
disease. 
Etiology 1 
content.onlinejacc.org/article.aspx?articleid=1910086 
• The hallmark of an ACS is the sudden imbalance 
between myocardial oxygen consumption 
(MVO2) and demand, which is usually the result 
of coronary artery obstruction.   
Etiology 2 
content.onlinejacc.org/article.aspx?articleid=1910086 
• The imbalance may also be caused by other 
excessive myocardial oxygen demand in the setting 
of a stable flow-limiting lesion; acute coronary 
insufficiency due to  vasospastic angina, coronary 
embolism, coronary arteritis; noncoronary causes 
(hypotension, severe anemia, hypertension, 
tachycardia, hypertrophic cardiomyopathy, severe 
aortic stenosis); nonischemic myocardial injury 
(myocarditis, cardiac contusion, cardiotoxic drugs); 
multifactorial causes (stress cardiomyopathy, 
pulmonary embolism, severe heart failure, sepsis). 
Mechanisms   
 In Reversible and Irreversible Ischemia Terms 1     
• UA develops, 
until local 
coronary 
circulation 
disturbances 
cross the time 
of reversible 
ischemia.  
 medicinembbs.blogspot.com/2011/06/what-is-difference-between-nstemi-and.html 
Dx - abbreviation for diagnosis. 
Mechanisms   
 In Reversible and Irreversible Ischemia Terms 2     
• MI develops, when 
local coronary 
circulation 
disturbances cross 
the time threshold 
and make the 
ischemia 
irreversible.   
 medicinembbs.blogspot.com/2011/06/what-is-difference-between-nstemi-and.html 
Dx - abbreviation for diagnosis. 
Mechanisms   
 Key Moments   
• Mechanisms of an ACS were selected by 
evolution and  consist at systemic and local 
levels  
• These mechanisms are aimed at providing 
most favourable of possible the ACS courses  
• Their disturbances build  complications of the 
ACS.  
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Systemic Level: 1   
• The response of body systems to an ACS is 
realized through stress and manifests itself as 
brain mediated sympathetic activation and 
increased functional activity of a 
hypothalamo-pituitary an adrenal systems 
with the change of functions of all target 
organs.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Systemic Level: 2 
• Course and outcome of the ACS, all other 
conditions being equal, an adequate 
organization of stress (eustress) becomes of 
primary importance  
• For STEMI leukocyte reactions are important 
for the further development of the process:  
• These reactions are triggered by the 
ejection of leukocytes from the depot to the 
systemic blood flow  
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Systemic Level: 3   
• Since the depot mainly contains 
neutrophils, leukocytosis appears as the 
shift in cell count, neutrophils are activated 
and migrate to the infarction zone by 
positive chemotaxis  
• Infarction zone products getting in the 
blood flow play the role of attractants for 
them.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Systemic Level: 4 
• The activation of neutrophils appears as 
hyperenzymemia, higher contents of eicosanoids, 
leukotrienes in particular, protein carbohydrate 
complexes, and other biologically active agents  
• Stress is changing as the process develops and 
leukocytosis declines with the leukogram changes 
•  Granulocyte counts decrease, and their 
functional activity is suppressed, while 
agranulocyte counts and their activity increase.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Systemic Level: 5     
• The structural change of the leukogram is 
the result of controlling effects of infarction 
zone products getting in the blood flow: 
neutrophil decay products from the 
infarction zone are repellents for 
neutrophils and attractants for 
agranulocytes.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Systemic Level: 6 
• As result an enzyme level in blood falls, 
while the proteins and protein-
carbohydrate complexes content grows. 
• These are the systemic manifestations of an 
inflammation process in the infarction zone  
• With the termination of an acute 
myocardial infarction phase, regulation 
problems disappear and not a trace remains 
of the stress.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Local Level 1 
The local level is 
the heart.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf amjmedsci.org/ 
The top panels show the infarction 
zone and the bottom panels show the 
border (periinfarction) zone. 
Mechanisms   
 Local Level 2 
The components of 
a pathologic 
process are not 
only changes in the 
infarction zone and 
recovery of heart 
shape and size but 
also adaptive 
changes of heart 
biomechanics. 
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf amjmedsci.org/ 
The top panels show the 
infarction zone and the bottom 
panels show the border 
(periinfarction) zone 
Mechanisms   
 Infarction Zone: 1  
• All that happens is inflammation: special, 
aseptic, alterative but still inflammation  
• The first one is ischemia, reversible myocardial 
changes (NSTEMI)   
• The transfer to irreversible changes (STEMI) 
marks the onset of necrosis, and with the 
transfer from ischemic changes in the infarction 
zone to the necrotic ones, the inflammation 
starts in accordance with its traditional scheme.  
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Infarction Zone: 2  
• The necrotized myocardium undergoes destruction, 
and decay products are removed through the peri-
infarction zone 
• The necrotized myocardium is specifically destroyed 
by neutrophil getting by chemotaxis from blood into 
the infarction zone and produsing cathepsins 
• Their migration rate is rather high, about 2-4 mm 
per hour and even the largest possible infarction is 
infiltrated by neutrophils in 6 hours at the most.  
 
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Infarction Zone: 3 
• At the same time, fibroblast precursors enter 
the infarction zone and the recovery process 
begins  
• It is impossible to separate necrotic and 
reparative processes, to look at them as the 
individual ones 
• They are synchronized and interconnected not 
only at the level of the infarction zone itself 
but also at the systemic blood level.  
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Infarction Zone: 4 
• The result of a natural inflammation course in 
the infarction zone is the formation of a full-
fledged scar in the place of necrosis   
• Maturation of a granulation tissue results in 
its consolidation followed by a decrease in 
infarction zone sizes 
• Depending on conditions, they can decrease 
by 25% or more.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Infarction Zone: 5 
• I should remind those who want to strongly 
intervene in the infarction zone that the 
phenomena occurring there (inflammation, 
compensatory and adaptive responses) are 
protective reactions originated as the result of 
evolution  
• We may intervene in these processes but 
carefully. 
 
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Periinfarction Zone 1 
• Systemic mechanisms and the infarction zone 
are interconnected through the periinfarction 
zone, first of all, through its microcirculatory 
bed.   
• Wastes from the infarction zone are removed 
through it, and the products necessary for 
reparative processes enter there the same 
way.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Periinfarction Zone 1 
• The larger the infarction–periinfarction zone 
interface, the better the mutual effect of the 
infarction zone and systemic control  
• The peri-infarction zone cannot be smaller 
than that required for uncomplicated healing 
of the infarction. 
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Heart Shape and Size 1      
• In the case of infarction, a part of a 
myocardium becomes disabled and its 
functions should be compensated    
• Hypertrophy of an intact myocardium 
develops  
• Healing of the infarction zone accompanied 
with the consolidation of scar leads to a 
decrease in its size.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Heart Shape and Size 2      
• The heart shape is remodeled in such a way 
that its anatomic proportions are restored to 
favor its pumping functions  
• In the best case, the traces of infarction are 
difficult to reveal, even after thorough 
investigations. 
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Complications: Frequency and Immediate Cause 1    
• Acute myocardial infarction is a complex and 
vulnerable process  
• In the most optimistic estimations, its 
complications are observed somewhere in a 
quarter of cases, if it is diagnosed and treated 
correctly.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Complications: Frequency and Immediate Cause 2 
• The immediate cause of complications is 
inadequate stress or distress   
• Have little patience, and we would see how 
distress is realized as complications. 
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Complications: Standard Mechanism 1     
• The cause of complications is (hyper reactive, 
hypo reactive or intermittent) distress  
• The mechanism of complications, irrespective 
of a distress type, is always the same, viz. 
desynchronization of necrotic and reparative 
processes.  
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Complications: Standard Mechanism 2     
• Desynchronization of necrosis and reparation 
leads to the loss of heart wall strength in the 
infarction zone with cardiac aneurysm or 
heart rupture outcomes.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Complications: Hyperreactive Distress 1  
• The result of hyperreactive distress is in 
intensive and rapid migration of polynuclears 
to the infarction zone with acceleration of 
necrosis and destruction of infarcted 
myocardium  and lag behind of reparative 
processes  
• There is the desynchronization.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Complications: Hyperreactive Distress 2  
• Fast destruction of myocardium in the 
infarction zone has one more consequence, 
viz. high concentration gradients of all 
products formed in it along the boundary with 
the peri-infarct zone with the electronic 
instability of a heart and as a result, 
arrhythmia.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Complications: Hyporeactive Distress 1   
• In this the case everything develops slowly.  
• Systemic reactions are sluggish or are absent 
at all  
• Thus, there are problems with the infiltration 
of polynuclears to the infarction zone and the 
necrotic phase is slow, which leads to the 
delay of reparative processes and their slow 
development.   
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Complications: Hyporeactive Distress 2  
• There is the desynchronization again  
• Hypo reactive distress with a sluggish disease 
pattern determines large sizes of aneurysm 
and as a rule, heart rupture occurs in the 
thinnest area of aneurysm. 
im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf 
Mechanisms   
 Complications: Intermittent Distress     
Intermittent distress 
means superposition 
of the above 
mechanisms by the 
formula 'out of the 
frying-pan into the 
fire‘ and everything 
becomes much more 
dangerous. 
 im.medicine.karazin.ua//downloads/presentations/Yabluchanskiy_Infarction_Strategy.pdf studyblue.com/#flashcard/view/15784631 
 US MLE TEST 
A 70-year-old man presents to the emergency room 
complaining of left-sided crushing substernal chest pain 
that began suddenly while he was walking his dog. He 
denies any past medical history, has not seen a physician 
recently, and has smoked one pack per day for the past 50 
years. Vital signs are: BP 85/50 mmHg, HR 50 bpm, RR 22, 
T 99.1 deg F. Physical exam shows an obese, nervous man 
with jugular venous distension and clear lung fields. An 
electrocardiogram shows ST elevations in II, III, and aVF. 
Which one of the following medications should not be 
administered to this patient?  
1.  Aspirin, 2.  Atorvastatin, 3.  Nitroglycerin, 
4.  Clopidogrel, 5.  Heparin   
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 3:  This patient is likely having a right ventricular 
infarct and therefore should not be given nitrates. Right ventricular 
myocardial infarctions (RVMI) are usually caused by an occlusion of 
the proximal right coronary artery. The diagnosis of RVMI can be 
strongly suspected when hypotension, raised jugular venous pressure 
(distended neck veins), and clear lung fields are present in a patient 
whose 12-lead electrocardiogram has findings of an inferior wall 
infarction as well as ST-elevation in lead V4R. These patients' cardiac 
output is highly dependent on pre-load, so any drug that limits 
venous return (nitrates/diuretics), slows heart rate (beta blockers), or 
decreases contractility (calcium channel blockers) are relatively 
contraindicated.  
Incorrect Answers: 
1, 2, 4, & 5: The other drug choices are appropriate for use in right 
and left ventricular infarcts and confer a mortality benefit. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Classification 
 International Classification of Diseases (ICD) 1 
icd10coded.com/cm/ch9/I20-I25/ 
Chapter IX 
Diseases of the circulatory system 
(I00-I99)  
I20-I25 Ischemic heart diseases 
I20.0 Unstable angina: Angina (crescendo, de 
novo effort, worsening effort), Intermediate 
coronary syndrome, Preinfarction syndrome   
I21 ST elevation (STEMI) and non-ST elevation 
(NSTEMI) myocardial infarction  
Classification 
 International Classification of Diseases (ICD) 2 
icd10coded.com/cm/ch9/I20-I25/ 
Chapter IX 
Diseases of the circulatory system 
(I00-I99)  
I20-I25 Ischemic heart diseases 
123 Certain current complications following ST 
elevation (STEMI) and non-ST elevation (NSTEMI) 
myocardial infarction (within the 28 day period) 
124 Other acute ischemic heart diseases 
Classification 
 Acute Coronary Syndromes Types  
medicinembbs.blogspot.com/2011/06/what-is-difference-between-nstemi-and.html hrombosisadviser.com/en/acs/a-leading-cause-of-mortality 
  
• STEMI - occlusive thrombus - ST elevation (and Q 
waves) - Cardiac Enzyme elevation present   
• NSTEMI - non-occlusive thrombus - NO ST/Q - 
Cardiac Enzyme elevation present   
• UA - non-occlusive thrombus - NO ST/Q - Cardiac 
Enzyme elevation absent.   
 
Classification 
 Myocardial Infarction   
metalyse.com/myocardial_infarction/types.html 
  • Anatomic perspective: transmural, nontransmural 
(subendocardial, subepicardial) 
• Localization:  anterior, lateral, posterior, septal, 
inferior, right ventricle   
• Clinical periodization: acutest (UA), acute 
(predominance  of necrotic processes), subacute 
(predominance  of reparative processes), 
postinfarction (consolidation of postinfarction scar) 
• Course: noncomplicated, complicated 
(hyperreactive, hyporeactive). 
 
Clinical Investigation  
 Symptoms 1 
• The cardinal symptom is chest pain, 
experienced as tightness around the chest and 
radiating to the left arm and the left angle of 
the jaw  
• This may be associated with diaphoresis 
(sweating), nausea and vomiting, as well 
as shortness of breath.   
en.wikipedia.org/wiki/Acute_coronary_syndrome#Signs_and_symptoms 
Clinical Investigation  
 Symptoms 2 
• In many cases, the sensation is "atypical", with 
pain experienced in different ways or even 
being completely absent (which is more likely in 
female patients and those with diabetes)   
• Some may report arrhythmia, anxiety or a sense 
of impending doom (angor animi) and a feeling 
of being acutely ill  
• The description of the chest discomfort as a 
pressure has little utility in aiding a diagnosis as 
it is not specific for ACS. 
en.wikipedia.org/wiki/Acute_coronary_syndrome#Signs_and_symptoms 
Clinical Investigation  
 Common Locations and Patterns of  Chest Pain 1 
s3.amazonaws.com/classconnection/12/flashcards/9384012/png/angina-153389544C30E11EA69.png eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
• The characteristics of discomfort-related to chest 
pain may be divided into four categories: 
location, character, duration and relationship to 
exertion and other exacerbating or relieving 
factors.   
Clinical Investigation  
 Common Locations and Patterns of  Chest Pain 2 
s3.amazonaws.com/classconnection/12/flashcards/9384012/png/angina-153389544C30E11EA69.png eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
• The discomfort caused by myocardial ischemia is 
usually located in the chest, near the sternum, 
but may be felt anywhere from the epigastrium 
to the lower jaw or teeth, between the shoulder 
blades or in either arm to the wrist and fingers. 
Clinical Investigation  
 Distribution of ACS  
quizlet.com/15191588/study-2-flash-cards/ 
Clinical Investigation  
 History 1 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/coronary-artery-disease/ 
• The history should include any current symptoms 
and a complete inventory of comorbid conditions  
• An inventory of cardiac risk factors, and a 
complete family history are essential components  
• The history should also include information about 
the character and location of discomfort, radiation 
of discomfort, associated symptoms, and 
precipitating, exacerbating, or alleviating factors.   
Clinical Investigation  
 History 2 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/coronary-artery-disease/ 
• The importance of the family history should 
not be underestimated  
• A detailed assessment, particularly of first-
degree relatives for the presence of coronary 
artery disease and age of diagnosis is 
imperative when evaluating a patient's risk 
factor profile. 
Clinical Investigation  
 Physical Examination 1 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/coronary-artery-disease/ 
• The results of the physical examination of a 
patient may be entirely normal  
• The presence of multiple risk factors or 
atherosclerosis symptoms increases the 
likelihood that a chest pain is related to 
myocardial ischemia  
• Evaluation should include measurements of 
blood pressure, the ankle-brachial index, 
cardiac and carotid arteries auscultation for 
bruits.   
Clinical Investigation  
 Physical Examination 2 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/coronary-artery-disease/ 
• Examination of the chest wall, neck, and 
shoulders for deformities and tenderness may 
be helpful in diagnosing musculoskeletal chest 
discomfort  
• The physical examination may help identify 
comorbid conditions that impact therapeutic 
risk and decision making.  
Clinical Investigation  
 Myocardial Infarction versus Stable Angina Comparison Chart 1 
diffen.com/difference/Myocardial_Infarction_vs_Stable_Angina 
Symptoms Myocardial Infarction Stable Angina 
Occurren-
ce of pain 
Occurs at any time Occurs due to 
physical  or 
emotional stress 
Modality 
of pain 
With damage to the 
heart and usually 
described as severe, 
steady, and crushing  
With no damage to 
the heart   
Clinical Investigation  
 Myocardial Infarction versus Stable Angina Comparison Chart 2 
diffen.com/difference/Myocardial_Infarction_vs_Stable_Angina 
Symptoms Myocardial Infarction Stable Angina 
Outcome May be fatal Usually not fatal 
Relieving 
factors of 
pain 
Symptoms persists 
after 15 min. and not 
relieved by rest or 
nitro  
Symptoms relieved 
by rest or nitro 
within 10-15 min.  
Duration 
of pain 
Usually lasts for more 
than 15 min. 
Usually for less than 
15 min.; discomfort 
is transient, lasting 
3-5 min. 
Clinical Investigation  
 Sequence of Changes in evolving 
noncomplicated MI  
nottingham.ac.uk/nursing/practice/resources/cardiology/acs/changes.php 
Clinical Investigation  
(ECG’ Localizing of Myocardial Injury) 
ems.sluhn.org/images/stemi_alert_opt.png 
Clinical Investigation  
 Complications 1 
• Complications may occur immediately following 
the heart attack, or may need time to develop  
• Acute complications may include heart 
failure; aneurysm of the left ventricle myocardium; 
ventricular septal rupture or free wall 
rupture; mitral regurgitation, in particular if the 
infarction causes dysfunction of the papillary 
muscle; Dressler's syndrome; and abnormal heart 
rhythms, such as ventricular fibrillation, ventricular 
tachycardia, atrial fibrillation, and heart block.   
en.wikipedia.org/wiki/Myocardial_infarction 
Clinical Investigation  
 Complications 2 
• Longer-term complications include heart failure, 
atrial fibrillation, and an increased risk of a second 
MI. 
en.wikipedia.org/wiki/Myocardial_infarction 
Clinical Investigation  
 Outcome of ACS  
quizlet.com/15191588/study-2-flash-cards/ 
Diagnosis 
  
• Blood tests: cardiac 
biomarkers; WBC; 
cholesterol and C-reactive 
protein levels  
• Electrocardiogram (ECG)  
• B-mode, Doppler and 
intravascular ultrasound  
• Vascular catheterization 
and angiogram  
• Other imaging tests. 
en.wikipedia.org/wiki/Coronary_artery_disease#Diagnosis afghanheart.files.wordpress.com/2013/04/troponins.jpg 
 US MLE TEST 
A 56-year-old male with a history of hypertension and 
type II diabetes presents to the emergency department 
with a complaint of crushing chest pain. The pain began 
30 minutes ago while mowing his lawn. He denies any 
radiation of the pain into his arms or neck. An EKG is 
obtained as is shown in Figure A. Which of the following 
is the strongest predictor of this patient's long-term 
prognosis from his presenting condition? 
1.  Patient age, 2.  Medical comorbidities, 3.  Maximum 
cardiac troponin T value measured, 4.  Time to initiation 
of aspirin therapy, 5.  Time to restoration of coronary 
blood flow.   
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 5:  This patient is suffering from an ST-
elevation myocardial infarction (STEMI). Time to 
restoration of coronary blood flow following a myocardial 
infarction is the strongest predictor of long-term 
prognosis for these patients.  
1,2,4: Patient age, medical comorbidities, and time to 
giving aspirin may all affect patient outcomes after MI; 
however, time to restoration of coronary blood flow is the 
strongest predictor of long-term prognosis., 3: The 
magnitude of troponin elevation has been shown to 
affect patient outcomes; however, time to restoration of 
coronary perfusion is a stronger predictor of patient 
prognosis. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Diagnosis 
(Initial Assessment of Patients with Suspected ACS)  
 eurheartj.oxfordjournals.org/content/37/3/267 
Diagnosis 
 Criteria for Diagnosis of MI 1 
A combination of criteria is required to meet the 
diagnosis of MI, namely the detection of an increase 
and/or decrease of a cardiac biomarker, preferably 
high-sensitivity cardiac troponin, with at least one 
value above the 99th percentile of the upper 
reference limit and at least one of the following:   
eurheartj.oxfordjournals.org/content/37/3/267 
Diagnosis 
 Criteria for Diagnosis of MI 2 
One of the following: symptoms of ischemia; new or 
presumed new significant ST-T wave changes or left 
bundle branch block on 12-lead ECG; development 
of pathological Q waves on ECG; imaging evidence 
of new or presumed new loss of viable myocardium 
or regional wall motion abnormality; intracoronary 
thrombus detected on angiography or autopsy. 
eurheartj.oxfordjournals.org/content/37/3/267 
Diagnosis 
(Cardiac Biomarkers)  
Biomarkers related to necrotic processes in 
myocardial infarction zone. 
quizlet.com/15191588/study-2-flash-cards/ 
Diagnosis 
 Indications for Measurement of Troponins 1  
• Cardiac troponin I and T have displaced myoglobin 
and creatine kinase-MB as the preferred markers of 
myocardial injury  
• Serum levels increase within 3-12 hours from the 
onset of chest pain, peak at 24-48 hours, and return 
to baseline over 5-14 days  
• Troponin levels may not be detectable for six hours 
after the onset of myocardial cell injury. The most 
sensitive early marker for myocardial infarction is 
myoglobin.  
patient.info/doctor/cardiac-enzymes-and-markers-for-myocardial-infarction 
Diagnosis 
 Indications for Measurement of Troponins 2 
• Troponin levels should be measured at presentation 
and again 10-12 hours after the onset of symptoms. 
When there is uncertainty regarding the time of 
symptom onset, troponin should be measured at 
twelve hours after the presentation. 
• The risk of death from an ACS is directly related to 
troponin level and patients with no detectable 
troponins have a good short-term prognosis.  
patient.info/doctor/cardiac-enzymes-and-markers-for-myocardial-infarction 
Diagnosis 
 Indications for Measurement of Troponins 3 
• Elevated troponin levels can occur in patients 
without an ACS and are associated with adverse 
outcomes in many other clinical situations, 
including congestive heart failure, sepsis, acute 
pulmonary embolism and chronic kidney disease. 
Other cardiac causes include myocarditis and aortic 
dissection. 
 
patient.info/doctor/cardiac-enzymes-and-markers-for-myocardial-infarction 
Diagnosis 
(Electrocardiogram)  
health-tutor.com/simple-cardiac-ischemia-ecg.html 
There are ST and T changes in leads II, III, aVF (solid 
red circles) – it is a suspicion of ischemia of the 
inferior myocardial wall. Similar change is outlined in 
the lead V6 (dashed circle). 
Diagnosis 
(Electrocardiogram)  
healio.com/cardiology/learn-the-heart/blogs/stemi-mi-ecg-pattern 
Inferior STEMI in acutest phase. 
Diagnosis 
(Electrocardiogram)  
healio.com/cardiology/learn-the-heart/blogs/stemi-mi-ecg-pattern 
An  inferior STEMI with a right bundle branch block on 
the ECG. Еhe reciprocal depression in lead I and aVL. 
Diagnosis 
(Criteria of Differentiation Noncomplicated and  
Complicated MI)  
meteopathy.com/zdorovye-i-bolezn/my-myocardial-infarction-phylosophy/2/ 
Criterion Type of acute myocardial infarction 
Noncomplicated 
with eureactive 
stress 
Complicated with 
hyperreactive 
distress 
Complicated with 
hyporeactive 
distress 
Blood leukocytes, E 9 1/l.: 1st day results and further 
dynamics 
7-11, rapid 
decrease 
>11, slow 
decrease 
<7, increase, then 
slow decrease 
Shift of leukocytes, arb. units: 1st day results and 
further dynamics 
3.0-6.5, rapid 
decrease 
>6.5, slow 
decrease 
<3.0, increase, 
then slow 
decrease 
Time of maximum activity of enzymes, hrs 16-22, rapid 
decrease 
>16, slow 
decrease 
>22, slow 
decrease 
Initial period of protein-carbohydrate complex 
growth, days 
1-2 >2 >2 
Period of reaching maximum protein-carbohydrate 
complex concentrations, days 
4-5 >5 >5 
Interval between maxima of enzymes and protein-
carbohydrate complexes, days 
>4 >6 >6 
Return of the ST segment on ECG to the isoline, hrs >36 >36 >36 
Treatment 
 Prehospital Care and Initial Management 1 
• All patients should be managed as if the pain is 
ischemic in origin, unless clear evidence to the 
contrary is established  
• Specific care includes intravenous access; 
supplemental oxygen; pulse oximetry; immediate 
administration of aspirin; nitroglycerin for active 
chest pain; telemetry and prehospital ECG, if 
available.  
 emedicine.medscape.com/article/155919-treatment#d5 
Treatment 
 Prehospital Care and Initial Management 2 
• Additional objectives include adequate analgesia 
(morphine); pharmacologic reduction of excessive 
sympathoadrenal and vagal stimulation; treatment 
of ventricular arrhythmias; support of cardiac 
output, and respiration  
• Prehospital fibrinolytic therapy (tissue-type 
plasminogen activator) , aspirin, and heparin may 
be given by paramedics, as guided by 
electrocardiographic findings, within 90 minutes of 
the onset of symptoms. 
 
 
 emedicine.medscape.com/article/155919-treatment#d5 
Treatment 
 Emergency Department Care and In-Hospital Management 
• Triage and evaluation: because ACS is a spectrum 
of conditions, initial evaluation to establish a 
working diagnosis is crucial, as this will dictate 
management owing to some differences in 
management steps and timelines for each 
component of the ACS spectrum  
• Initial management:  restoration of the balance 
between oxygen supply and demand to prevent 
further ischemia; pain relief, prevention and 
treatment of complications. 
  emedicine.medscape.com/article/155919-treatment#d5 
Treatment 
 Suggested Algorithm for Triaging Patients with Chest Pain  
 emedicine.medscape.com/article/1910735-overview#showall 
Treatment 
 Presumed ACS  and NSTEMI 1 
• The accepted management is empirical treatment 
with aspirin, a second platelet inhibitor such as 
clopidogrel, and heparin (usually a low-molecular 
weight heparin such as enoxaparin), with 
intravenous glyceryl trinitrate and opioids if the 
pain persists  
• A blood test is generally performed for cardiac 
troponins twelve hours after onset of the pain and 
if this is positive, coronary angiography is typically 
performed on an urgent basis  
/en.wikipedia.org/wiki/Acute_coronary_syndrome#Signs_and_symptoms 
Treatment 
 Presumed ACS  and NSTEMI 1 
• If there is no evidence of ST segment elevation on 
the electrocardiogram, delaying 
urgent angioplasty until the next morning is not 
inferior to doing so immediately.   
/en.wikipedia.org/wiki/Acute_coronary_syndrome#Signs_and_symptoms 
Treatment 
 STEMI  
• If the ECG confirms changes suggestive of MI, 
thrombolytics may be administered or primary 
coronary angioplasty may be performed  
• The time frame for door-to-needle thrombolytic 
administration should be within 30 minutes, 
whereas the door-to-balloon Percutaneous 
Coronary Intervention (PCI) time should be less 
than 90 minutes. 
/en.wikipedia.org/wiki/Acute_coronary_syndrome#Signs_and_symptoms 
Treatment 
 Absolute and Relative Contraindications to Fibrinolytic 
Therapy  
 emedicine.medscape.com/article/155919-treatment#d25 
Absolute Contraindications Relative Contraindications 
Prior intracranial hemorrhage 
Structural cerebral vascular lesion 
Intracranial neoplasm 
Ischemic stroke within the past 3 months 
(except for acute stroke within 4.5 hours) 
Suspected aortic dissection 
Active bleeding or bleeding diathesis 
(excluding menses) 
Significant closed-head or facial trauma within 
3 months 
Intracranial or intraspinal surgery within 2 
months 
Severe uncontrolled hypertension 
(unresponsive to emergency therapy) 
For streptokinase (no longer marketed in the 
US): Prior treatment within previous 6 months 
Chronic, severe, poorly controlled 
hypertension 
Systolic pressure >180 mm Hg or diastolic 
pressure >110 mm Hg 
History of prior ischemic stroke >3 months 
Dementia 
Intracranial pathology 
Traumatic or prolonged CPR (>10 minutes) 
Recent (within 2-4 weeks) internal bleeding 
Noncompressible vascular punctures 
Pregnancy 
Active peptic ulcer disease 
Current use of anticoagulants 
For streptokinase: prior exposure (>5 days 
previously) or prior allergic reaction to these 
agents 
CPR = cardiopulmonary resuscitation 
Treatment 
Fibrinolytic Agents 
 emedicine.medscape.com/article/155919-treatment#d25 
Fibrinolytic Agent Dose Fibrin 
Specificity 
Antigenic Patency Rate 
Streptokinase (no 
longer marketed in 
the US) 
1.5 million units IV given over 30–60 min No Yes 60%–68% 
Tenecteplase 
 
 
 
(TNK-tPA) 
30 mg for weight <60 kg 
35 mg for 60–69 kg 
40 mg for 70–79 kg 
45 mg for 80–89 kg 
50 mg for >90 kg 
++++ No 85% 
Reteplase (rPA) 10-U IV boluses given 30 min apart ++ No 84% 
Alteplase (tPA) Bolus 15 mg followed by infusion 0.75 mg/kg 
for 30 min (maximum 50 mg), then 0.5 mg/kg 
(maximum 35 mg) over the next 60 min; total 
dose not to exceed 100 mg. 
++ No 73%-84% 
IV = intravenous; rPA = recombinant human tissue plasminogen activator; STEMI = ST-elevation myocardial 
infarction; tPA = tissue plasminogen activator; US = United States of America. 
 US MLE TEST 
An intern covering the night shift at an ICU is called to the room of a 
75-year-old hypotensive man. The patient experienced an 
anterolateral myocardial infarction four days prior and underwent 
cardiac catheterization with successful revascularization of his left 
anterior descending artery. He was doing well prior to 45 minutes 
ago when he began to complain of weakness, fatigue, and renewed 
chest pain. A nurse obtained his blood pressure, which was 80/40, 
and was not able to auscultate his heart sounds due to muffling. The 
intern found the patient lethargic and confused and noted distended 
neck veins. He checked for pulsus paradoxus and noted a 15 mmHg 
difference in the systolic pressure during respiration. He runs out of 
the room to gather supplies. Which of the following emergent 
therapies is warranted? 
1.  Pericardiocentesis, 2.  Repeat cardiac catheterization , 3.  Mitral 
valve repair, 4.  Intra-aortic balloon pump, 5.  Cardioversion.    
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
 US MLE TEST 
Correct Answer 1:  This man has pulsus paradoxus and is 
experiencing cardiac tamponade caused by an anterior 
wall rupture and requires emergent pericardiocentesis. 
Incorrect Answers: 
2: This patient is not having another myocardial infarction 
and so would not benefit from a repeat cardiac 
catheterization., 3: This patient did not have a papillary 
muscle rupture and so would not benefit from a mitral 
valve repair., 4: An intra-aortic balloon pump is not 
indicated for a free wall rupture emergently., 5: There is 
no indication that the patient is having an issue with his 
rhythm and so would not benefit from cardioversion. 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Treatment 
 Cardioprotective Medications  
• Inhibitors of the renin-angiotensin-
aldosterone (RAA) system 
• Beta blockers 
• Statins 
 
en.wikipedia.org/wiki/Acute_coronary_syndrome#Signs_and_symptoms 
Treatment 
 Troponin in MI reperfusion  
dpmls89.wordpress.com/2012/09/09/a-quick-review-of-troponins/ 
Treatment 
 Components of Delay in ACS and Ideal Time Intervals 
for Intervention  
eurheartj.oxfordjournals.org/content/33/20/2569#T3 
Treatment 
 Revascularization  
• Percutaneous 
coronary 
intervention 
• Coronary artery 
bypass surgery 
• Revascularization vs. 
medical therapy 
hemodinamiadelsur.com.ar/journals/journal_130.asp 
Treatment 
 Stress’ Optimization 1 
• Upon hyperreactive distress and accelerated 
necrotic processes, our aim is to decrease the 
former and to retard the latter, using beta 
blockaders and anti-inflammatory drugs 
administered enterally and/or parenterally  
• Hyporeactive distress and retarded necrotic 
processes require the prescription of alpha -and 
beta- adrenostimulators, bacterial and leukocytic 
pyrogens, leukopoiesis stimulants, using several 
ways of administration.   
meteopathy.com/zdorovye-i-bolezn/my-myocardial-infarction-phylosophy/3/ 
Treatment 
 Stress’ Optimization 2 
• Upon intermittent distress, the attitude should be 
even more careful to prevent wave recurrence of 
necrotic processes. 
meteopathy.com/zdorovye-i-bolezn/my-myocardial-infarction-phylosophy/3/ 
Lifestyle Modifications and Cardiac 
Rehabilitation 1  
• Extensive patient education that includes 
providing easily understood and culturally 
sensitive written and verbal instructions about 
symptoms of ACS, as well as how and when to 
seek emergency care, in addition to providing 
instructions about medication types, purposes, 
doses, frequency, and side effects.  
emedicine.medscape.com/article/155919-treatment#d7 
Lifestyle Modifications and Cardiac 
Rehabilitation 2  
• Dietary changes that adopt a low-fat and low-
salt diet with dietary counseling, smoking 
cessation, up-to-date vaccination, and an 
increase in physical activity and exercise  
• Aerobic exercise training within a cardiac 
rehabilitation programs, with the need for an 
evaluation of both exercise capacity and 
exercise-associated risk. 
emedicine.medscape.com/article/155919-treatment#d7 
Prognosis  
• Six-month mortality rates in the Global 
Registry of Acute Coronary Events (GRACE) 
were 13% for patients with NSTEMI ACS and 
8% for those with unstable angina  
• The prognosis varies greatly depending on a 
person's health, the extent of the heart 
damage, and the treatment given. 
 emedicine.medscape.com/article/1910735-overview#a6 
Prophylaxis 1 
• Lifestyle recommendations include the 
adoption of a Mediterranean-type 
diet, maintaining alcohol intake within 
recommended limits, exercising to the point of 
mild breathlessness for 20–30 minutes every 
day, stopping smoking, and trying to achieve a 
healthy weight. 
• Exercise is both safe and effective even if 
people have had stents or heart failure.  
en.wikipedia.org/wiki/Myocardial_infarction 
Prophylaxis 2 
• People are usually started on several long-
term medications: aspirin, warfarin, beta 
blockers, ACE inhibitors, angiotensin II 
receptor antagonist, statins,   aldosterone 
antagonists. 
• Previous studies suggested a benefit 
from omega-3 fatty acid supplementation but 
this has not been confirmed. 
en.wikipedia.org/wiki/Myocardial_infarction 
Abbreviations  
• ACE - angiotensin converting 
enzyme  
• ACS - acute coronary 
syndrome 
• ALT - alanine 
aminotransferase 
• ECG – electrocardiography 
• ICD - International 
Classification of Diseases 
• LDH - lactate dehydrogenase 
• NQMI non-Q-wave 
myocardial infarction 
 
 
 
 
• NSTEMI - non–ST-segment 
elevation myocardial 
infarction  
• MI – acute myocardial 
infarction  
• MVO2 - myocardial oxygen 
consumption  
• STEMI - ST-segment 
elevation myocardial 
infarction 
• QMI Q-wave myocardial 
infarction 
Diagnostic and treatment guidelines 
• 2015 ESC Guidelines for the management of acute coronary 
syndromes in patients presenting without persistent ST-
segment elevation  
• 2014 AHA/ACC Guideline for the Management of Patients 
With Non–ST-Elevation Acute Coronary Syndromes 
• 2014 ESC/EACTS Guidelines on myocardial revascularization  
• ESC Guidelines for the management of acute myocardial 
infarction in patients presenting with ST-segment elevation  
• Recommendations for best-practice STEMI management in 
Ontario 
 
 
 
